Prognostic and clinical significance of HER-2 low expression in early-stage gastric cancer.

Yang, Tao; Xu, Rui; You, Junhao; Li, Fang; Yan, Bing; Cheng, Jia-Nan

Yang, Tao; Xu, Rui; You, Junhao; Li, Fang; Yan, Bing; Cheng, Jia-Nan.

Afiliação

Yang T; Department of Oncology, Hainan Hospital of Chinese PLA General Hospital, Sanya, 572013, Hainan, China.
Xu R; Department of Oncology, Hainan Hospital of Chinese PLA General Hospital, Sanya, 572013, Hainan, China.
You J; Department of Oncology, Hainan Hospital of Chinese PLA General Hospital, Sanya, 572013, Hainan, China.
Li F; Department of Oncology, Hainan Hospital of Chinese PLA General Hospital, Sanya, 572013, Hainan, China.
Yan B; Department of Oncology, Hainan Hospital of Chinese PLA General Hospital, Sanya, 572013, Hainan, China. y_bing41@163.com.
Cheng JN; Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, People's Republic of China. 982263928@qq.com.

BMC Cancer ; 22(1): 1168, 2022 Nov 12.

Article em En | MEDLINE | ID: mdl-36371187

Assuntos

Neoplasias Gástricas; Humanos; Prognóstico; Estudos Retrospectivos; Receptor ErbB-2/metabolismo; Intervalo Livre de Doença

Palavras-chave

Clinical characteristics; Gastric cancer; HER-2; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google